Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results

BACKGROUND: This study investigated the effect of oral dimercapto succinic acid (DMSA) therapy for children with autism spectrum disorders ages 3-8 years. METHODS: Phase 1 involved 65 children who received one round of DMSA (3 days). Participants who had high urinary excretion of toxic metals were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, James B, Baral, Matthew, Geis, Elizabeth, Mitchell, Jessica, Ingram, Julie, Hensley, Andrea, Zappia, Irene, Newmark, Sanford, Gehn, Eva, Rubin, Robert A, Mitchell, Ken, Bradstreet, Jeff, El-Dahr, Jane
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774660/
https://www.ncbi.nlm.nih.gov/pubmed/19852789
http://dx.doi.org/10.1186/1472-6904-9-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774660/
https://www.ncbi.nlm.nih.gov/pubmed/19852789
http://dx.doi.org/10.1186/1472-6904-9-16

Ejemplares similares